IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery
- Yang Q. , et al.
2. Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice
- Gallinaro A. , et al.
3. Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19
- Kole E. , et al.
5. VLP (Virus-Like Particles) Vaccines – Current Knowledge and Future Directions
- Meghana P. , et al.
6. Engineered Virus-Like Particles (VLPs): A Modern Approach to Infectious Diseases and Metabolic Disorders
- Rehman A.U. , et al.
7. Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
- Chulanetra M. , et al.
8. A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity
- Li Y. , et al.
9. Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
- Khudainazarova N.S. , et al.
11. Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy
- Bouazzaoui A. , et al.
12. Modularized viromimetic polymer nanoparticle vaccines (VPNVaxs) to elicit durable and effective humoral immune responses
- Huang Z. , et al.
13. Controlling the Quality of Nanodrugs According to Their New Property—Radiothermal Emission
- Petrov G.V. , et al.
14. Virus-like particles as powerful vaccination strategy against human viruses
- Hadj Hassine I. , et al.
15. COVID-19: The vaccine development strategies
- Yan M.Z. , et al.
16. mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
- Okuyama R. , et al.
17. An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
- Mathew D.S. , et al.
18. Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
- Nagar G. , et al.
19. Viral protein-based nanoparticles (part 2): Pharmaceutical applications
- Mellid-Carballal R. , et al.
20. COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
- Zasada A.A. , et al.
21. An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines
- Setyo Utomo D.I. , et al.
22. Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
- Chattopadhyay A. , et al.
23. Nanocarrier vaccine therapeutics for global infectious and chronic diseases
- Zarreen Simnani F. , et al.
24. Platforms, advances, and technical challenges in virus-like particles-based vaccines
- Gupta R. , et al.
25. A perspective on SARS-CoV-2 virus-like particles vaccines
- Gao X. , et al.